Robert Spurr, President Salix Pharmaceuticals

Bausch Health’s Sal­ix pi­lots study to shine light on chron­ic liv­er dis­ease and push back on stereo­types

Oc­to­ber is both breast can­cer aware­ness and liv­er dis­ease aware­ness month. While there’s no doubt which con­di­tion draws more at­ten­tion dur­ing the month, Sal­ix wants to change that.

Sal­ix, Bausch Health’s gas­troen­terol­o­gy arm, pi­lot­ed its first chron­ic liv­er dis­ease re­port and physi­cian sur­vey with re­sults out this week aimed at rais­ing aware­ness and dis­pelling stereo­types.

While 4.5 mil­lion peo­ple have chron­ic liv­er dis­ease or cir­rho­sis – which is even more than 3.8 mil­lion women di­ag­nosed with breast can­cer – the re­search found chron­ic liv­er dis­ease “has not re­ceived the at­ten­tion or lev­el of ef­fort need­ed for ad­e­quate pre­ven­tion, di­ag­no­sis, and stan­dard­iza­tion of its man­age­ment.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.